Anteris Competitors

Pink Sheets . USA . 
Stock . Anteris Technologies
AMEUF Stock  USD 14.70  0.83  5.34%   
Anteris Technologies competes with Medtronic PLC, CONMED, Glaukos Corp, Integer Holdings, and Orthopediatrics Corp; as well as few others. The company classifies itself under Healthcare sector and is part of Medical Devices industry. Analyzing Anteris Technologies competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Anteris Technologies to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Anteris Technologies Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Anteris Technologies competition on your existing holdings.
  
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Anteris Technologies' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
12.3714.7017.03
Details
Intrinsic
Valuation
LowRealHigh
14.0216.3518.68
Details
Naive
Forecast
LowNextHigh
12.3514.6817.01
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
14.4715.2516.04
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Anteris Technologies. Your research has to be compared to or analyzed against Anteris Technologies' peers to derive any actionable benefits. When done correctly, Anteris Technologies' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Anteris Technologies.

Anteris Technologies Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Anteris Technologies and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of Anteris and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Anteris Technologies does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
AXGN
+ 0.83
FNA
KIDS
+ 0.74
GKOS
CNMD
+ 0.62
MDT
FNA
+ 0.54
MDT
TLIS
+ 0.53
LIVN
AXGN
+ 0.51
CNMD
  
High negative correlations   
AXGN
- 0.81
ITGR
FNA
- 0.79
ITGR
TLIS
- 0.64
FNA
ITGR
- 0.64
CNMD
TLIS
- 0.62
CNMD
AXGN
- 0.56
TLIS

Risk-Adjusted Indicators

There is a big difference between Anteris Pink Sheet performing well and Anteris Technologies Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Anteris Technologies' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Anteris Technologies Competitive Analysis

The better you understand Anteris Technologies competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Anteris Technologies' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Anteris Technologies' competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
AMEUF MDT CNMD GKOS ITGR KIDS LIVN FNA TLIS AXGN
 5.34 
 14.70 
Anteris
 1.12 
 80.38 
Medtronic
 1.82 
 70.01 
CONMED
 0.17 
 100.93 
Glaukos
 4.55 
 123.27 
Integer
 1.86 
 31.20 
Orthopediatrics
 1.67 
 55.94 
LivaNova
 4.08 
 9.64 
Paragon
 0.00 
 9.20 
Talis
 1.43 
 6.87 
Axogen
Market Volatility
(90 Days Market Risk)
Not too volatile
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Somewhat reliable
Somewhat reliable
Somewhat reliable
Market Performance
(90 Days Performance)
Solid
Very Weak
Very Weak
OK
Good
OK
Modest
Very Weak
OK
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Low
Very Low
Low
Low
Low
Low
Very Small
Below Average
High
Below Average
Current Valuation
(Equity Enterprise Value)
Under Valued
Under Valued
Under Valued
Over Valued
Fairly Valued
Under Valued
Under Valued
Under Valued
Over Valued
Under Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Buy
Buy
Strong Buy
Strong Buy
Buy
Strong Buy
Strong Buy
Strong Sell
Strong Buy
Trade Advice
(90 Days Macroaxis Advice)
Strong Buy
Strong Hold
Cautious Hold
Cautious Hold
Hold
Strong Sell
Cautious Hold
Sell
Strong Hold
Cautious Hold
Current Ratio
4.31
1.76
2.75
6.78
2.7
4.75
2.92
3.66
12.51
4.52
Net Asset
29.48 M
90.95 B
2.3 B
940.41 M
2.94 B
449.59 M
2.43 B
340.7 M
98.34 M
196.83 M
Profit Margin
N/A
0.13
0.0518
-0.43
0.0568
-0.14
0.0152
-0.22
N/A
-0.14
EBITDA
(20.21 M)
9.04 B
182.19 M
(82.12 M)
266.17 M
(8.38 M)
159.81 M
(21.77 M)
(60.7 M)
(15.91 M)
Operating Margin
-5.05
0.19
0.12
-0.44
0.13
-0.21
0.0681
-0.19
-74.13
-0.0744
Current Valuation
196.49 M
125 B
3.2 B
5.09 B
4.97 B
641.95 M
3.34 B
847.37 M
(40.64 M)
342.4 M
Price To Book
10.09
2.05
2.75
10.52
2.55
1.96
2.24
4.78
0.22
3.29
Retained Earnings
(69 M)
30.39 B
452.53 M
(599.07 M)
771.35 M
(197.74 M)
(966.48 M)
(115.63 M)
(539.96 M)
(281.3 M)
Current Asset
17 M
23.6 B
393.34 M
104.14 M
574.6 M
44 M
240.72 M
N/A
N/A
35.05 M
Five Year Return
N/A
2.18
0.92
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Beta
0.62
0.78
1.34
1.1
1.12
1.18
0.94
1.01
1.74
1.02
Number Of Employees
31
95 K
4 K
907
10.5 K
247
2.9 K
574
99
426
Shares Outstanding
13.9 M
1.33 B
30.79 M
50.19 M
33.5 M
23.79 M
53.96 M
82.91 M
1.82 M
43.69 M
Cash Flow From Operations
(18.81 M)
6.04 B
125.35 M
(57.76 M)
179.62 M
(27.05 M)
74.91 M
(63.89 M)
(53.24 M)
(5.72 M)
Annual Yield
N/A
0.034
0.011
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Debt
4.07 M
24.36 B
991.25 M
383.74 M
1.04 B
23.76 M
640.4 M
112.03 M
19.67 M
69.29 M
Return On Equity
-2.55
0.0817
0.0816
-0.27
0.0617
-0.0555
0.0141
-0.3
-0.63
-0.22
Z Score
29.0
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return On Asset
-0.84
0.0423
0.0347
-0.0796
0.0399
-0.0372
0.0176
-0.0784
-0.3
-0.0684
Book Value Per Share
2.26
38.95
27.12
9.4
45.58
16.13
23.7
2.15
37.93
2.22
Number Of Shares Shorted
N/A
12.43 M
846.97 K
3.49 M
2.43 M
1.04 M
3.31 M
2.43 M
13.3 K
1.73 M
Current Liabilities
4 M
7.17 B
119.72 M
20.36 M
213.84 M
8.51 M
31.45 M
N/A
N/A
3.71 M
Total Asset
29.48 M
90.95 B
2.3 B
940.41 M
2.94 B
449.59 M
2.43 B
340.7 M
98.34 M
196.83 M
Debt To Equity
0.13
0.51
1.45
0.68
0.75
0.14
0.4
0.24
0.19
0.71
Short Ratio
N/A
1.96
8.22
6.98
8.24
5.53
3.59
4.15
1.84
4.81
Target Price
N/A
94.0
110.57
106.55
124.86
40.0
67.56
18.0
5.0
13.67
Last Dividend Paid
N/A
2.75
0.8
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Shares Owned By Institutions
28.34
85.26
99.47
96.49
98.41
71.58
99.5
49.63
43.9
77.24
Market Capitalization
218.95 M
107.94 B
2.2 B
5.13 B
4.04 B
728.57 M
2.98 B
833.21 M
16.42 M
304.5 M
Price To Earning
-3.2
20.44
188.03
94.7
35.01
-10.06
78.67
N/A
N/A
-47.07
Price To Earnings To Growth
N/A
1.52
5.29
1.64
1.63
N/A
0.6
N/A
N/A
N/A
Price To Sales
30.51
3.29
1.84
15.44
2.43
4.97
2.48
3.93
7.26
1.98
Net Income
(22.91 M)
3.78 B
64.46 M
(134.66 M)
90.65 M
(20.97 M)
17.55 M
(47.84 M)
(62.01 M)
(21.72 M)
Earnings Per Share
-2.15
3.15
2.04
-2.78
2.69
-0.92
0.32
-0.58
-34.12
-0.51
Shares Owned By Insiders
13.27
0.1
0.54
3.51
1.59
31.89
0.5
39.89
8.3
5.05
Revenue
7.79 M
31.23 B
1.24 B
314.71 M
1.6 B
148.73 M
1.15 B
216.39 M
412 K
159.01 M
Working Capital
13 M
12.62 B
304.92 M
321.45 M
396.7 M
184.83 M
653.17 M
164.57 M
68.91 M
57.57 M
Cash And Equivalents
33.1 M
1.54 B
33.35 M
391.19 M
15.59 M
51.16 M
109.02 M
73 M
165.37 M
58.03 M
Cash Per Share
2.39
8.59
1.09
8.22
0.47
2.52
2.04
0.95
6.21
1.37
Gross Profit
6.15 M
21.71 B
575.75 M
213.88 M
359.01 M
90.66 M
696.73 M
148.93 M
(149.4 M)
114.44 M
Day Typical Price
14.7
80.41
71.09
101.78
121.92
31.01
55.15
9.73
9.12
6.89
Accumulation Distribution
N/A
51010.85
0.0444
14645.84
48982.42
1921.56
0.0422
22321.96
0.0261
2833.44
Market Facilitation Index
N/A
N/A
3.25
0.0
0.0
0.0
2.36
0.0
0.24
0.0
Daily Balance Of Power
(9,223,372,036,855)
(1.11)
(0.40)
(0.06)
0.9781
0.7917
0.3898
(0.72)
N/A
(0.62)
Period Momentum Indicator
(0.83)
(0.91)
(1.30)
(0.17)
5.36
0.57
0.92
(0.41)
N/A
(0.10)
Rate Of Daily Change
0.95
0.99
0.98
1.0
1.05
1.02
1.02
0.96
1.0
0.99
Day Median Price
14.7
80.42
71.64
102.21
121.25
30.92
54.76
9.78
9.08
6.9
Price Action Indicator
(0.41)
(0.50)
(2.27)
(1.36)
4.7
0.56
1.64
(0.34)
0.12
(0.08)
Relative Strength Index
99.74
87.82
55.77
88.2
57.8
N/A
65.72
83.45
42.97
51.73
Coefficient Of Variation
673.59
(1,442)
(548.88)
1140.53
744.21
2289.58
1539.4
(5,291)
1205.99
(1,018)
Mean Deviation
1.24
0.8052
1.84
1.54
1.17
2.51
1.77
3.03
1.84
2.16
Jensen Alpha
0.3636
(0.17)
(0.55)
0.0156
0.1254
(0.07)
(0.01)
(0.36)
0.1812
(0.52)
Total Risk Alpha
0.0206
(0.23)
(0.88)
(0.11)
(0.01)
(0.32)
(0.20)
(0.69)
(0.15)
(0.73)
Sortino Ratio
N/A
N/A
N/A
0.0414
0.0701
0.0178
0.0408
N/A
0.054
N/A
Downside Variance
N/A
N/A
N/A
3.63
2.3
7.43
3.38
N/A
4.46
N/A
Standard Deviation
2.63
1.09
2.72
1.99
1.5
3.29
2.62
4.35
2.52
3.06
Kurtosis
9.97
1.71
5.59
0.1831
1.11
0.8738
7.68
4.1
1.86
7.47
Potential Upside
4.86
1.37
2.96
3.33
2.49
6.44
3.21
6.65
5.0
3.84
Treynor Ratio
1.96
(0.09)
(1.00)
0.0943
0.2466
0.0553
0.08
(0.03)
0.9364
(0.13)
Maximum Drawdown
11.11
6.33
15.57
7.99
7.45
15.51
15.28
31.62
14.7
21.07
Variance
6.91
1.19
7.42
3.95
2.25
10.84
6.88
18.9
6.38
9.39
Market Risk Adjusted Performance
1.97
(0.08)
(0.99)
0.1043
0.2566
0.0653
0.09
(0.02)
0.9464
(0.12)
Risk Adjusted Performance
0.1002
(0.04)
(0.11)
0.0615
0.0896
0.0353
0.0481
(0)
0.0592
(0.05)
Skewness
0.4508
0.3035
(1.84)
0.0419
(0.47)
0.7687
1.87
0.4055
0.806
(1.69)
Semi Deviation
N/A
N/A
N/A
1.71
1.28
2.55
1.74
N/A
1.94
N/A
Information Ratio
0.1122
(0.16)
(0.22)
0.0397
0.0709
0.0147
0.0286
(0.04)
0.0452
(0.13)
Value At Risk
N/A
(1.95)
(6.07)
(3.31)
(2.10)
(4.65)
(2.79)
(5.04)
(3.17)
(4.17)
Expected Short fall
N/A
N/A
N/A
(1.66)
(1.26)
(2.90)
(2.34)
N/A
(2.23)
N/A
Downside Deviation
N/A
N/A
N/A
1.9
1.52
2.73
1.84
N/A
2.11
N/A
Semi Variance
N/A
N/A
N/A
2.93
1.64
6.5
3.03
N/A
3.75
N/A

Anteris Technologies Competition Performance Charts

Five steps to successful analysis of Anteris Technologies Competition

Anteris Technologies' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Anteris Technologies in relation to its competition. Anteris Technologies' competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Anteris Technologies in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Anteris Technologies' competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Anteris Technologies, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Anteris Technologies position

In addition to having Anteris Technologies in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Compulsion Thematic Idea Now

Compulsion
Compulsion Theme
Companies involved in research, development, and manufacturing of products with compulsion characteristics such as cigarettes, addictive drugs and alcohol. The Compulsion theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Compulsion Theme or any other thematic opportunities.
View All  Next Launch
Check out Anteris Technologies Correlation with its peers.
You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Complementary Tools for Anteris Pink Sheet analysis

When running Anteris Technologies' price analysis, check to measure Anteris Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anteris Technologies is operating at the current time. Most of Anteris Technologies' value examination focuses on studying past and present price action to predict the probability of Anteris Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anteris Technologies' price. Additionally, you may evaluate how the addition of Anteris Technologies to your portfolios can decrease your overall portfolio volatility.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Stocks Directory
Find actively traded stocks across global markets
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Transaction History
View history of all your transactions and understand their impact on performance
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Altman
Z Score
Details
Intrinsic
Valuation
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Technical
Analysis
Details
Please note, there is a significant difference between Anteris Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Anteris Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anteris Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY